Cytek Biosciences (CTKB) Inventory (2020 - 2026)

Cytek Biosciences (CTKB) has 7 years of Inventory data on file, last reported at $49.8 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 9.8% year-over-year to $49.8 million; the trailing twelve-month figure through Mar 2026 stood at $49.8 million (up 9.8% YoY), and the FY2025 full-year result was $48.4 million, up 10.33% from the prior year.
• Inventory for Q1 2026 stood at $49.8 million, up from $48.4 million in the prior quarter.
• Across five years, Inventory topped out at $69.5 million in Q1 2023 and bottomed at $38.0 million in Q1 2022.
• The 5-year median for Inventory is $49.5 million (2025), against an average of $52.0 million.
• The widest annual swing landed in 2023, when Inventory jumped 82.99%; it then sank 30.02% in 2024.
• A 5-year view of Inventory shows it stood at $48.2 million in 2022, then advanced by 26.42% to $60.9 million in 2023, then fell by 27.9% to $43.9 million in 2024, then grew by 10.33% to $48.4 million in 2025, then grew by 2.81% to $49.8 million in 2026.
• The last three Inventory figures came in at $49.8 million (Q1 2026), $48.4 million (Q4 2025), and $51.6 million (Q3 2025), per Business Quant data.

Peer Comparison